784 related articles for article (PubMed ID: 17513708)
1. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Umpierrez GE; Smiley D; Zisman A; Prieto LM; Palacio A; Ceron M; Puig A; Mejia R
Diabetes Care; 2007 Sep; 30(9):2181-6. PubMed ID: 17513708
[TBL] [Abstract][Full Text] [Related]
2. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
3. Intensive insulin protocol implementation and outcomes in the medical and surgical wards at a Veterans Affairs Medical Center.
Chen HJ; Steinke DT; Karounos DG; Lane MT; Matson AW
Ann Pharmacother; 2010 Feb; 44(2):249-56. PubMed ID: 20103610
[TBL] [Abstract][Full Text] [Related]
4. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
Chant C; Wilson G; Friedrich JO
Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
[TBL] [Abstract][Full Text] [Related]
5. Dosing of insulin glargine in the treatment of type 2 diabetes.
Barnett A
Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
[TBL] [Abstract][Full Text] [Related]
7. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
Umpierrez GE; Smiley D; Jacobs S; Peng L; Temponi A; Mulligan P; Umpierrez D; Newton C; Olson D; Rizzo M
Diabetes Care; 2011 Feb; 34(2):256-61. PubMed ID: 21228246
[TBL] [Abstract][Full Text] [Related]
8. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
9. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
Yang W; Ji Q; Zhu D; Yang J; Chen L; Liu Z; Yu D; Yan L
Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
[TBL] [Abstract][Full Text] [Related]
10. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
Meneghini L; Koenen C; Weng W; Selam JL
Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
[TBL] [Abstract][Full Text] [Related]
11. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
12. Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.
Umpierrez GE; Smiley D; Hermayer K; Khan A; Olson DE; Newton C; Jacobs S; Rizzo M; Peng L; Reyes D; Pinzon I; Fereira ME; Hunt V; Gore A; Toyoshima MT; Fonseca VA
Diabetes Care; 2013 Aug; 36(8):2169-74. PubMed ID: 23435159
[TBL] [Abstract][Full Text] [Related]
13. 70/30 insulin algorithm versus sliding scale insulin.
Schoeffler JM; Rice DA; Gresham DG
Ann Pharmacother; 2005 Oct; 39(10):1606-10. PubMed ID: 16091416
[TBL] [Abstract][Full Text] [Related]
14. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
[TBL] [Abstract][Full Text] [Related]
15. BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA.
Bueno E; Benitez A; Rufinelli JV; Figueredo R; Alsina S; Ojeda A; Samudio S; Cáceres M; Argüello R; Romero F; Echagüe G; Pasquel F; Umpierrez GE
Endocr Pract; 2015 Jul; 21(7):807-13. PubMed ID: 26121460
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit.
Clayton SB; Mazur JE; Condren S; Hermayer KL; Strange C
Crit Care Med; 2006 Dec; 34(12):2974-8. PubMed ID: 17075371
[TBL] [Abstract][Full Text] [Related]
17. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy.
Golightly LK; Jones MA; Hamamura DH; Stolpman NM; McDermott MT
Pharmacotherapy; 2006 Oct; 26(10):1421-32. PubMed ID: 16999652
[TBL] [Abstract][Full Text] [Related]
18. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
[TBL] [Abstract][Full Text] [Related]
19. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress.
Siegelaar SE; Kulik W; van Lenthe H; Mukherjee R; Hoekstra JB; Devries JH
Diabetes Obes Metab; 2009 Jul; 11(7):709-14. PubMed ID: 19320663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
